Lachnoclostridium is a mucin-degrading bacteria that can impact both glycan composition and mucus thickness, and its increased abundance is associated with NAFLD in rat models [99]. The gene discussed is MUC5AC; the disease is metabolic dysfunction-associated steatotic liver disease.